Skip to main content
TipRanks
Go Ultimate75% OFF

Universal (UVV) AI Stock Analysis

625 Followers
UVV

Universal

(NYSE:UVV)

Select Model
Rating:51Neutral
Price Target:$40.00â–²(13.67% Upside)
Action:reiterated
Date:11/09/26

Overall score reflects pressured fundamentals (TTM net loss, weaker margins, and sharply lower free cash flow) and a bearish technical setup (below key moving averages with negative MACD). These are partially offset by the company’s balance-sheet support and management’s second-half recovery expectations, plus a high dividend yield, but near-term execution and profitability normalization remain key risks.

Positive Factors
Contracted global tobacco supply modelLong-standing B2B relationships and specification-based contracts can support recurring demand and make Universal an embedded supplier for major tobacco manufacturers. Its sourcing, processing, storage and logistics capabilities also create service value beyond selling raw agricultural inputs.
Negative Factors
Broad revenue and profit deteriorationThe decline spans revenue, operating income and net income, showing that current weakness is affecting the consolidated business rather than a single isolated metric. Persistently lower earnings would reduce internal funding capacity and make recovery dependent on improved shipments and execution.

Universal Key Performance Indicators (KPIs)

Operating Income by SegmentMeasures operating profit for each segment to show which parts of the business actually generate earnings after costs; exposes margin differences, operational efficiency, and segments that are subsidizing others—critical for forecasting earnings, dividend capacity, and where cost cuts or investment can improve returns.

-$25.00M$0.00$25.00M$50.00M$75.00M$100.00MJun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Tobacco remains the clear earnings engine but its profits have become more volatile and compressed recently as inventory write‑downs and market oversupply erode margins; Ingredients has delivered revenue progress yet is barely profitable and was further hit by Shanks’ goodwill impairment and execution shortfalls, turning an expected growth lever into a near‑term drag. ‘Other’ is immaterial and intermittently negative. Management’s inventory normalization and Shanks remediation are the key catalysts—successful execution would stabilize consolidated operating income, while setbacks would prolong profit pressure despite healthy liquidity and a supported dividend.

Data provided by:The Fly

Universal (UVV) vs. SPDR S&P 500 ETF (SPY)

-30%-20%-10%0%10%20%30%UVV-29.04%SPY+13.11%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$912.58M
Dividend Yield
9.38%
Average Volume (3M)
373.99K
Price to Earnings (P/E)
-351.9
Beta (1Y)
0.11
Revenue Growth
-8.88%
EPS Growth
-102.19%
Country
US
Employees
11,250
Sector
Consumer Defensive
Sector Strength
62
Industry
Tobacco

Universal Business Overview & Revenue Model

Company Description

Universal Corporation is a global agricultural enterprise specializing in the processing and supply of leaf tobacco and a diverse range of plant-based ingredients. Its activities are organized into two primary segments: Tobacco Operations and Ingredi...

How the Company Makes Money

Universal makes money mainly by selling products and services through two operating segments. 1) Tobacco Operations (primary revenue and earnings driver): - Sale of processed leaf tobacco: Universal purchases leaf tobacco from growers or local market...

Universal Earnings Call Summary

Earnings Call Date:Nov 04, 2026(Q2-2027)|% Change Since:-11.47%|Next Earnings Date:Feb 10, 2027
Earnings Call SentimentNeutral

The call presented a mixed outlook. Current results were significantly weaker, with double-digit revenue declines, lower operating income and net income, an Ingredients operating loss, higher net debt and persistent market and supply challenges. These issues were balanced by management's confidence in second-half tobacco shipments, inventory reduction, potential additional customer demand, expected margin improvement, strong liquidity and ongoing long-term transformation initiatives.

Positive Updates

Tobacco Commitments and Inventory Progress
Customer commitments remained in line with the full-year sales plan. Uncommitted inventory declined to 19% as of September 30, within the company's target range, and estimated unsold flue-cured and burley stocks were approximately 134 million kilos, down approximately 45 million kilos from June 30.

Negative Updates

Tobacco Operations Revenue and Profit Declines
Second-quarter Tobacco Operations revenue was $534 million, down 19% year over year, while segment operating income was $44 million compared with $65 million. First-half revenue was $972 million, down 17%, and segment operating income was $47 million, down 53%. Lower tobacco shipment volume was the primary reason, as customers delivered shipping instructions later in the market cycle because of the shift to market oversupply.

Company Guidance

Management expects shipments and financial results to be heavily weighted to the second half, particularly the third and fourth quarters, with uncommitted inventories reducing further from 19% within the target range as of September 30. Gross profit percent of revenue is expected to remain inside the 17% to 19% range, tobacco operating margin is forecast to show some improvement and be comparable with fiscal '26, again within that kind of 17% to 19% range, SG&A is expected to be between $300 million and $310 million, and the $70 million range for interest expense was described as a pretty fair way to see it based on year-to-date interest expense and trend. Additional El Niño-related sales opportunities would be in addition to the sales plan but were not quantified, while working capital usage is expected to moderate, with an aim to delever the balance sheet and reduce interest expense. The Ingredients initiatives are expected to continue through next fiscal year, although management said it is difficult to say exactly how results will play out quarter by quarter.

Universal Financial Statement Overview

Summary

Mixed fundamentals. Income statement weakness is the main drag: TTM revenue is down (~4.6%) with meaningful margin compression and a small net loss. Balance sheet is still supported by substantial equity, but leverage has risen (debt now close to equity). Cash flow is positive in TTM, yet highly volatile with a sharp free-cash-flow decline (~-85%), reducing flexibility despite liquidity.

Income Statement

54Neutral

Balance Sheet

63Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.72B2.92B2.95B2.75B2.57B2.10B
Gross Profit447.73M512.02M548.88M536.10M458.29M408.93M
EBITDA172.57M230.13M301.05M288.68M248.57M222.53M
Net Income-2.46M32.64M95.05M119.60M124.05M86.58M
Balance Sheet
Total Assets3.03B2.77B2.99B2.94B2.64B2.59B
Cash, Cash Equivalents and Short-Term Investments47.02M62.18M260.12M55.59M64.69M81.65M
Total Debt1.23B939.82M1.10B1.06B849.32M741.11M
Total Liabilities1.61B1.31B1.49B1.46B1.20B1.20B
Stockholders Equity1.39B1.42B1.46B1.44B1.40B1.34B
Cash Flow
Free Cash Flow24.38M80.27M264.37M-140.65M-65.23M-8.32M
Operating Cash Flow87.68M129.10M326.97M-74.63M-10.56M44.88M
Investing Cash Flow-51.97M-42.96M-58.82M-60.00M-50.35M-142.66M
Financing Cash Flow-76.89M-284.34M-63.23M125.67M38.95M-16.76M

Universal Technical Analysis

Technical Analysis SentimentNegative
Last Price35.19

Price Trends

50DMA40.70Negative
100DMA44.51Negative
200DMA47.76Negative

Market Momentum

MACD-1.20Positive
RSI26.00Positive
STOCH2.54Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UVV, the sentiment is Negative. The current price of 35.19 is below the 20-day moving average (MA) of 39.00, below the 50-day MA of 40.70, and below the 200-day MA of 47.76, indicating a bearish trend. The MACD of -1.20 indicates Positive momentum. The RSI at 26.00 is Positive, neither overbought nor oversold. The STOCH value of 2.54 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UVV.

Universal Risk Analysis

Universal disclosed 24 risk factors in its most recent earnings report. Universal reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

3 New Risks
1.We are not currently eligible to use a Form S-3 registration statement, which could impair our capital-raising activities.Q1, 2025
2.We have identified a material weakness in our internal control over financial reporting and, if we are not able to remediate the material weakness, or if we identify additional material weaknesses in the future or otherwise fail to design and maintain effective internal control over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent misstatements due to fraud or error.Q1, 2025
3.Epidemics, pandemics or similar widespread public health concerns could adversely affect our business, financial condition, results of operations and demand for our products and services.Q1, 2024

Universal Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

UVV against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
BTIBTI68Neutral$127.64B15.2613.42%5.65%4.47%117.22%
PMPM68Neutral$300.40B28.14-119.68%3.12%7.91%24.06%
MOMO65Neutral$128.85B15.72-279.72%5.63%2.41%-7.63%
TPBTPB65Neutral$944.98M33.476.97%0.66%23.78%-51.37%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
UVVUVV51Neutral$912.58M-351.90-0.17%9.38%-8.88%-102.19%
XXIIXXII38Underperform$203.82K0.00-68.11%―-15.53%99.45%

* Consumer Defensive Sector Average

Performance Comparison

-100%-50%0%UVVMOBTIPMXXIITPBDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
UVV and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
UVVUniversal Corporation35.19-13.94-28.37%
MOAltria76.2621.7739.94%
BTIBritish American Tobacco58.506.8313.21%
PMPhilip Morris International192.7342.4028.20%
XXII22nd Century Group0.37-13942.26-100.00%
TPBTurning Point Brands Inc47.53-50.03-51.28%

Universal Corporate Events

Executive/Board Changes

Universal Expands Board With Appointment of Independent Director

Neutral
Nov 4, 2026

On November 4, 2026, Universal increased its board to 10 members and appointed Gregory R. Friedman as an independent director. Friedman brought more than 30 years of financial, operational and strategic leadership, including senior roles at Mura Tech...

Business Operations and StrategyPrivate Placements and Financing

Universal temporarily relaxes leverage limits in credit pact

Neutral
Oct 13, 2026

On October 9, 2026, Universal Corporation amended its December 2025 Credit Agreement with JPMorgan Chase Bank, N.A. and other lenders, revising the covenant that limits its Total Net Leverage Ratio. The maximum ratio was temporarily increased to 3.75...

Business Operations and StrategyExecutive/Board Changes

Universal terminates ingredients vice president amid succession search

Negative
Sep 18, 2026

Universal Corporation reported that J. Patrick O’Keefe, its Vice President of Ingredients, was terminated without cause on September 14, 2026, effective September 15, 2026, even though he had previously notified the company on July 29, 2026, of his i...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026